Classic and Global Hemostasis Testing in Pregnancy and during Pregnancy Complications

 

Тромбодинамика

глобальный тест для ранней диагностики нарушений системы свертывания крови – выявления рисков кровотечений и тромбообразования


Исследования осуществляются компанией "ГемаКор Лабс" при грантовой поддержке Фонда "Сколково"

 

 

Fazoil I. Ataullakhanov, PhD1,2,3,4 Ekaterina M. Koltsova,1 Anna N. Balandina, PhD1,5Ilya I. Serebriyskiy, MD6 Tatiana A. Vuimo, PhD1 Mikhail A. Panteleev, PhD1,3,4,5

1Department of Biophysics and Systems Biology, Dmitry Rogachev Federal Research and Clinical Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia
2The Laboratory of Cell Biophysics, Centre for Theoretical Problems of Physicochemical Pharmacology RAS, Moscow, Russia
3Faculty of Physics, M.V. Lomonosov Moscow State University, Moscow, Russia
4Faculty of Biological and Medical Physics, Moscow Institute of Physics and Technology, Dolgoprudny, Russia
5The Laboratory of Molecular Mechanisms of Hemostasis, Centre for Theoretical Problems of Physicochemical Pharmacology RAS, Moscow, Russia
6Hemostasis Committee, Russian Laboratory Federation, Moscow, Russia

Semin Thromb Hemost DOI: 10.1055/s-0036-1592303

Abstract

Pregnancy is associated with a significant procoagulant shift in the hemostatic system balance as well as other metabolic changes. Pregnancy can thereby provoke manifestation of otherwise dormant disorders of hemostasis (e.g., thrombophilia), or even cause new, pregnancy-specific disorders (e.g., HELLP syndrome). Application and interpretation of laboratory assays of hemostasis in pregnancy is particularly challenging, because normal physiological ranges are no longer applicable, and because the most dangerous and complex changes are not detected by classic routine coagulation/platelet assays. New global assays of coagulation and of platelet-dependent hemostasis appear to be promising in this respect, but are still far from clinical practice and rarely appear in current patient management guidelines. These global assays require a high level of research to identify their relationship to clinically significant outcomes. Here, we review the state-of-the-art knowledge of the molecular changes in the hemostatic system in normal pregnancy and during pregnancy-related complications (preeclampsia, thrombotic microangiopathies, antiphospholipid syndrome, etc.). We also discuss the sensitivity of various classic and innovative assays to these pregnancy-associated changes, and describe current and potential future applications of these assays in meeting specific clinical needs.

https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0036-1592303